MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.clim.2025.110453

Медицинская библиотека · Clinical immunology (Orlando, Fla.) · 2025

Ex vivo T-lymphopoiesis assays assisting corrective treatment choice for genetically undefined T-lymphocytopenia.

Golwala Zainab M, Spiridou Goncalves Helena, Moirangthem Ranjita Devi, Evans Grace, Lizot Sabrina, de Koning Coco, Garrigue Alexandrine, Corredera Marta Martin, Ocampo-Godinez Juan Moises, Howley Evey, Kricke Susanne, Awuah Arnold, Obiri-Yeboa Irene, Rai Rajeev, Sebire Neil, Bernard Fanette, Bordon Cueto De Braem Victoria, Boztug Kaan, Cole Theresa, Gennery Andrew R, Hackett Scott, Hambleton Sophie, Holm Mette, Kusters Maaike A, Klocperk Adam, Marzollo Antonio, Marcus Nufar, Nademi Zohreh, Pachlopnik Schmid Jana, Pichler Herbert, Sellmer Anna, Soler-Palacin Pere, Soomann Maarja, Torpiano Paul, van Montfrans Joris, Nierkens Stefan, Adams Stuart, Buckland Matthew, Gilmour Kimberly, Worth Austen, Thrasher Adrian J, Davies E Graham, André Isabelle, Kreins Alexandra Y

СтатьяПеревод в очереди

Аннотация

Persistent selective T-lymphocytopenia is found both in SCID and congenital athymia. Without molecular diagnosis, it is challenging to determine whether HCT or thymus transplantation ought to be performed. Ex vivo T-lymphopoiesis assays have been proposed to assist clinical decision-making for genetically undefined patients. We investigated 20 T-lymphocytopenic patients, including 13 patients awaiting first-line treatment and 7 patients with failed immune reconstitution after previous HCT or thymus transplantation. Whilst developmental blocks in ex vivo T-lymphopoiesis indicated hematopoietic cell-intrinsic defects, successful T-lymphocyte differentiation required careful interpretation, in conjunction with clinical status, immunophenotyping, and genetic investigations. Of the 20 patients, 13 proceeded to treatment, with successful immune reconstitution observed in 4 of the 6 patients post-HCT and 4 of the 7 patients after thymus transplantation, the latter including two patients who had previously undergone HCT. Whilst further validation and standardization are required, we conclude that assessing ex vivo T-lymphopoiesis during the diagnostic pathway for genetically undefined T-lymphocytopenia improves patient outcomes by facilitating corrective treatment choice.

Для цитирования: Golwala Zainab M, Spiridou Goncalves Helena, Moirangthem Ranjita Devi, Evans Grace, Lizot Sabrina, de Koning Coco, Garrigue Alexandrine, Corredera Marta Martin, Ocampo-Godinez Juan Moises, Howley Evey, Kricke Susanne, Awuah Arnold, Obiri-Yeboa Irene, Rai Rajeev, Sebire Neil, Bernard Fanette, Bordon Cueto De Braem Victoria, Boztug Kaan, Cole Theresa, Gennery Andrew R, Hackett Scott, Hambleton Sophie, Holm Mette, Kusters Maaike A, Klocperk Adam, Marzollo Antonio, Marcus Nufar, Nademi Zohreh, Pachlopnik Schmid Jana, Pichler Herbert, Sellmer Anna, Soler-Palacin Pere, Soomann Maarja, Torpiano Paul, van Montfrans Joris, Nierkens Stefan, Adams Stuart, Buckland Matthew, Gilmour Kimberly, Worth Austen, Thrasher Adrian J, Davies E Graham, André Isabelle, Kreins Alexandra Y. Ex vivo T-lymphopoiesis assays assisting corrective treatment choice for genetically undefined T-lymphocytopenia.. Clinical immunology (Orlando, Fla.). 2025. DOI: 10.1016/j.clim.2025.110453.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.